sorafenib
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of hepatocellular carcinoma, advanced renal cell carcinoma, as well as locally advanced or metastatic differentiated thyroid carcinoma that is unresponsive to radioactive iodine therapy.
Form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
Manufacturer: Bayer AG (full production cycle)
-
The drug is prescribed for the treatment of hepatocellular carcinoma, advanced renal cell carcinoma, as well as locally advanced or metastatic differentiated thyroid carcinoma that is unresponsive to radioactive iodine therapy.
Form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
Manufacturer: Nacto Pharma Limited